Sex differences in CTEPH heart function and recovery
Part of Heart & circulation, Lungs & breathing clinical trials.
This study looks at how CTEPH (a type of high blood pressure in the lungs caused by blood clots) affects heart function differently in men and women. It uses heart ultrasounds and pressure measurements to see if recovery after surgery differs by sex.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with chronic thromboembolic pulmonary hypertension (CTEPH)
- You had an echocardiogram (heart ultrasound) within 3 months of your diagnosis that clearly shows how your right heart squeezes
- You had a right heart catheterization (a test that measures heart pressures) when you were diagnosed
- You are not pregnant
- For one part of the study, you must have had PTE surgery and a follow-up echocardiogram 3-9 months later
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a minimally invasive procedure called balloon pulmonary angioplasty (BPA) helps patients with chronic blood clots in the lungs improve their heart function and overall recovery. Researchers will measure blood flow patterns in your arteries before and after the procedure to understand how well your heart recovers.
This study uses special heart scans (CMR with 4D flow) to see how a procedure called BPA affects blood flow in the heart and lungs for people with a rare type of high blood pressure in the lungs (CTEPH). It may help doctors understand how well BPA works beyond just symptoms.
This trial tests whether starting specific medicines for CTEPH and then doing balloon pulmonary angioplasty (BPA) can improve how well the right side of the heart is working. It may help people who cannot have surgery (PTE) and are newly starting CTEPH/PAH-targeted treatment.
This trial is for people with a type of long-term blood clot in the lungs (CTEPH) who have been taking riociguat for at least 12 weeks. It will see what happens when the medication is stopped, focusing on how the right side of the heart is doing.
This trial is for people who had a pulmonary embolism (a blood clot in the lungs) in the last 3 to 12 months and are still on blood thinners. It aims to find early signs of a serious condition called CTEPH (chronic blood clots in the lungs) so treatment can start sooner.
This study builds a registry to learn about people with chronic blood-clot lung disease (CTEPD/CTEPH) and what symptoms and test results look like over time. It may help clinicians better understand the condition and improve future care, since your participation supports data collection rather than a new drug.
Hear when a new CTEPH trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.